County
Lane County Medical Control Board
The current listed document is more than 24 months old and may be outdated.
Drugs and doses47
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride8
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 975 mg | PO | not captured | standing | page 37 |
| Other | adult | 975 mg | PO | not captured | standing | page 37 |
| Mild to moderate pain | adult | 975 mg | PO | not captured | standing | page 37 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | page 53 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 53 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 39 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 39 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| COPD | adult | 2.5 mg | NEB | not captured | standing | pages 41, 85 |
| COPD | peds | 2.5 mg | NEB | not captured | standing | pages 41, 85 |
| Hyperkalemia | adult | 2.5 mg | NEB | not captured | standing | page 41 |
| Hyperkalemia | peds | 2.5 mg | NEB | not captured | standing | page 41 |
| Other | adult | 2.5 mg | NEB | not captured | standing | pages 41, 85 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 41 |
| Other | peds | 2.5 mg | NEB | not captured | standing | pages 41, 85 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 41 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | page 43 |
| Other | adult | 150 mg | IV | not captured | standing | page 43 |
| Other | adult | 300 mg | IV/IO | not captured | standing | page 43 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 43 |
| Other | peds | 5 mg/kg | IV | not captured | standing | page 43 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 324 mg | PO | not captured | standing | page 45 |
| Other | adult | 324 mg | not captured | not captured | standing | page 45 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV | not captured | standing | page 47 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | page 47 |
| Organophosphate poisoning | adult | 1 mg | IV | not captured | standing | page 47 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV | not captured | standing | page 47 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV | not captured | standing | page 51 |
| Other | adult | 1 g | IV | not captured | standing | page 51 |
| Other | adult | 1 g | IV | not captured | standing | page 51 |
| Other | adult | 1 g | IV | not captured | standing | page 52 |
| Other | adult | 1 g | IV | not captured | standing | page 52 |
| Other | adult | 1 g | IV | not captured | standing | page 52 |
| Other | peds | 20 mg/kg | IV | not captured | standing | page 52 |
| Other | peds | 20 mg/kg | IV | not captured | standing | page 52 |
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Fentanyl8
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | pages 59, 60, 249, 259 |
| Other | adult | 25 g | IV/IO | not captured | standing | page 240 |
| Other | peds | 10.5 g | IV/IO | not captured | standing | page 60 |
| Other | peds | 13.3 g | IV/IO | not captured | standing | page 60 |
| Other | peds | 16.5 g | IV/IO | not captured | standing | page 60 |
| Other | peds | 4.25 g | IV/IO | not captured | standing | page 60 |
| Other | peds | 5.25 g | IV/IO | not captured | standing | page 60 |
| Other | peds | 6.5 g | IV/IO | not captured | standing | page 60 |
| Other | peds | 8.25 g | IV/IO | not captured | standing | page 60 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 2–10 mg | IV/IO/IM | not captured | standing | page 61 |
| Seizure | peds | 0.1–0.3 mg/kg | IV/IO/IM | not captured | standing | page 61 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 63 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 50 mg | IV/IO/IM | not captured | standing | page 65 |
| Agitation | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 65 |
| Anaphylaxis | adult | 50 mg | IV/IM/PO | not captured | standing | page 65 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM/PO | not captured | standing | page 65 |
| Nausea / vomiting | adult | 50 mg | IV/IM | not captured | standing | page 65 |
| Other | adult | 50 mg | IV/IM | not captured | standing | page 65 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 65 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 10–20 mcg/kg | IV | not captured | standing | page 67 |
| Other | adult | 10 mcg/kg | IV | not captured | standing | pages 67, 68 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 69, 70 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 69, 70 |
| Anaphylaxis | peds | 0.01 mg/kg | IV | not captured | standing | page 70 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 69, 70 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 69, 240 |
| Cardiac arrest | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 69, 70 |
| Croup | peds | 5 mg | NEB | not captured | standing | page 70 |
| Croup | peds | 5 mL | NEB | not captured | standing | page 70 |
| Other | adult | 0.3 mg | IM | not captured | standing | pages 69, 70 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | pages 69, 70 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 70 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 70 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 70 |
| Other | peds | 0.1 mg | IM | not captured | standing | page 70 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 71 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 71 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mcg/kg | IV/IO | not captured | standing | pages 73, 74 |
| Other | adult | 1 mcg/kg | IV/IO | not captured | standing | pages 73, 74, 156, 157 |
| Other | adult | 3 mcg/kg | IV/IO | not captured | standing | pages 73, 74 |
| Other | adult | 3 mcg/kg | IV/IO | not captured | standing | pages 73, 74, 156, 157 |
| Other | adult | 50 mcg | IV/IO/IM | not captured | standing | page 73 |
| Other | adult | 50 mcg | IV | not captured | standing | page 73 |
| Other | adult | 50–100 mcg | IV/IO/IM | not captured | standing | pages 31, 73 |
| Other | peds | 1 mcg/kg | IV/IO | not captured | standing | pages 73, 74 |
| Other | peds | 1 mcg/kg | IV/IO | not captured | standing | pages 73, 74, 156, 157 |
| Other | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | page 74 |
| Other | peds | 3 mcg/kg | IV/IO | not captured | standing | pages 73, 74 |
| Other | peds | 3 mcg/kg | IV/IO | not captured | standing | pages 73, 74, 156, 157 |
| Severe pain | adult | 2 mcg/kg | IN | not captured | standing | pages 73, 74 |
| Severe pain | adult | 50–100 mcg | IV/IO/IM | not captured | standing | pages 73, 74 |
| Severe pain | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | pages 73, 74 |
| Severe pain | peds | 2 mcg/kg | IN | not captured | standing | pages 73, 74 |
G–L Glucagon, Heparin, Hydromorphone, Hydroxocobalamin, Ipratropium, Ketamine, Ketorolac, Lidocaine8
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IM | not captured | standing | page 75 |
| Other | peds | 0.1 mg/kg | IM | not captured | standing | page 75 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 60 unit/kg | IV | not captured | standing | page 79 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.25–0.5 mg | IV | not captured | standing | page 83 |
| Other | adult | 0.25–0.5 mg | IV | not captured | standing | pages 31, 83 |
| Other | adult | 0.5 mg | IV | not captured | standing | page 83 |
| Other | adult | 0.5 mg | IV | not captured | standing | page 83 |
| Other | adult | 1 mg | IM | not captured | standing | page 83 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | pages 56, 189 |
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | pages 56, 189 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | pages 56, 189 |
| Cyanide poisoning | peds | 70 mg/kg (max 5 g) | IV | not captured | standing | pages 56, 189 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | NEB | not captured | standing | page 85 |
| Other | peds | 0.25 mg | NEB | not captured | standing | page 85 |
| Other | peds | 0.5 mg | NEB | not captured | standing | page 85 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mg/kg | IV/IO | not captured | standing | pages 87, 88 |
| Other | adult | 1–2 mg/kg | IM | not captured | standing | pages 87, 88 |
| Other | adult | 25 mg | IV/IO | not captured | standing | page 87 |
| Other | adult | 50 mg | IM | not captured | standing | pages 87, 88 |
| Other | peds | 0.5–1 mg/kg | IV/IO | not captured | standing | pages 87, 88 |
| Other | peds | 1–2 mg/kg | IM | not captured | standing | pages 87, 88 |
| Other | peds | 25 mg | IM | not captured | standing | pages 87, 88 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 88 |
| RSI induction | adult | 4 mg/kg | IM | not captured | standing | page 88 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | page 88 |
| RSI induction | peds | 4 mg/kg | IM | not captured | standing | page 88 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15 mg | IV | not captured | standing | page 89 |
| Severe pain | adult | 30 mg | IM | not captured | standing | page 89 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20–40 mg | IO | not captured | standing | page 91 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 91 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Olanzapine, Ondansetron, Oral Glucose, Oxytocin11
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV/IO | not captured | standing | pages 93, 189, 240 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 93 |
| Other | adult | 4 g | IV/IO | not captured | standing | pages 93, 189 |
| Other | peds | 25 mg/kg | IV/IO | not captured | standing | pages 93, 189, 240 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IM | not captured | standing | page 95 |
| Adrenal crisis | peds | 2 mg/kg | IV/IM | not captured | standing | page 95 |
| Other | adult | 125 mg | IV/IM | not captured | standing | page 95 |
| Other | peds | 2 mg/kg | IV/IM | not captured | standing | page 95 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 97, 98 |
| Other | adult | 1 mg | IV/IM/IN | not captured | standing | page 98 |
| Other | adult | 2 mg | IV/IO/IN | not captured | standing | pages 97, 98 |
| Other | adult | 2 mg | IV/IO/IN | not captured | standing | page 97 |
| Other | adult | 2 mg | IV/IO/IM/IN | not captured | standing | page 97 |
| Other | adult | 2 mg | IV/IM/IN | not captured | standing | page 98 |
| Other | adult | 4 mg | IM | not captured | standing | pages 97, 98 |
| Other | adult | 4 mg | IM | not captured | standing | page 97 |
| Other | adult | 4 mg | IV/IO/IM/IN | not captured | standing | page 97 |
| Other | peds | 0.1 mg/kg | IV/IO/IN | not captured | standing | pages 97, 98 |
| Other | peds | 0.1 mg/kg | IM | not captured | standing | pages 97, 98 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 97, 98 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 99 |
| Severe pain | peds | 0.1–0.2 mg/kg | IV/IO/IM | not captured | standing | page 99 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | IV/IO/IM | not captured | standing | page 101 |
| Other | peds | 0.1 mg/kg (max 2 mg) | IN | not captured | standing | pages 101, 102 |
| Other | peds | 0.1 mg/kg (max 2 mg) | IV/IO/IM | not captured | standing | pages 101, 102 |
| Other | peds | 0.1 mg/kg (max 2 mg) | IN | not captured | standing | pages 101, 102 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4 mg | SL | not captured | standing | page 103 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 103 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 4 mcg | IV | not captured | standing | pages 105, 106, 189 |
| Other | adult | 4 mcg | IV | not captured | standing | pages 105, 189 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | PO | not captured | standing | page 107 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM/PO | not captured | standing | page 109 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM/PO | not captured | standing | page 109 |
| Other | adult | 4 mg | IV/IM/PO | not captured | standing | page 109 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 109 |
| Other | peds | 4 mg | PO | not captured | standing | page 109 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | pages 77, 225, 249, 259 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IV | not captured | standing | pages 113, 189 |
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 113 |
P–R Pralidoxime, Prochlorperazine, Promethazine, Proparacaine, Rocuronium5
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1200 mg | IM | not captured | standing | page 115 |
| Other | peds | 25–50 mg/kg | IM | not captured | standing | page 115 |
| Other | peds | 25–50 mg/kg | IV | not captured | standing | page 115 |
Prochlorperazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5–10 mg | IV/IM | not captured | standing | page 117 |
| Other | adult | 5–10 mg | IV/IM | not captured | standing | page 117 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV | not captured | standing | page 119 |
| Nausea / vomiting | adult | 25 mg | IM | not captured | standing | page 119 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | TOP | not captured | standing | page 121 |
| Other | adult | 1–2 drop | TOP | not captured | standing | page 121 |
| Other | adult | 1–2 drop | TOP | not captured | standing | page 121 |
| Other | peds | 1–2 drop | TOP | not captured | standing | page 121 |
| Other | peds | 1–2 drop | TOP | not captured | standing | page 121 |
| Other | peds | 1–2 drop | TOP | not captured | standing | page 121 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | pages 123, 156, 157 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 123, 156, 157 |
S–Z Sodium Bicarbonate, Succinylcholine, Tranexamic Acid, Tranexamic Acid-Txa, Whole Blood, Ziprasidone, Ziprasidone-Geodon7
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 125, 126 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | pages 125, 126 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 125, 126 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | pages 125, 126 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 125, 126 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 125, 126 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 127, 128, 156, 157 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 127, 128, 156, 157 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV/IO | not captured | standing | pages 129, 189 |
Tranexamic Acid-Txa
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 129, 130 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 129, 130 |
| Other | adult | 2 g | IV/IO | not captured | standing | pages 129, 130 |
Whole Blood
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 unit | IV/IO | not captured | standing | pages 49, 50 |
| Other | peds | 10 mL/kg | IV/IO | not captured | standing | pages 49, 50 |
| Traumatic arrest | adult | 1 unit | IV/IO | not captured | standing | pages 49, 50 |
| Traumatic arrest | peds | 10 mL/kg | IV/IO | not captured | standing | pages 49, 50 |
Ziprasidone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | IM | not captured | standing | pages 65, 131 |
| Other | adult | 10–20 mg | IM | not captured | standing | page 131 |
Ziprasidone-Geodon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IM | not captured | standing | page 131 |
| Other | adult | 10–20 mg | IM | not captured | standing | page 131 |
| Other | adult | 10–20 mg | IM | not captured | standing | page 131 |
Cite this
Lane County Medical Control Board, United States EMS Protocol Census. 192 dose entries, effective 2024-10-01.
https://protoquiz.com/census/agencies/lane-county-medical-control-board/
The census is free and not for sale. Only public agencies are named.